Apex Biotechnology Corp. (1733.TW)
- Previous Close
30.35 - Open
29.95 - Bid 30.10 x --
- Ask 30.15 x --
- Day's Range
29.95 - 30.40 - 52 Week Range
26.40 - 36.25 - Volume
137,222 - Avg. Volume
355,091 - Market Cap (intraday)
3.009B - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
23.70 - EPS (TTM)
1.27 - Earnings Date --
- Forward Dividend & Yield 1.10 (3.65%)
- Ex-Dividend Date May 17, 2024
- 1y Target Est
--
Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemosmart gold hemoglobin screening systems. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.
www.apexbio.comRecent News: 1733.TW
View MorePerformance Overview: 1733.TW
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1733.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1733.TW
View MoreValuation Measures
Market Cap
3.03B
Enterprise Value
2.60B
Trailing P/E
23.90
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.65
Price/Book (mrq)
1.66
Enterprise Value/Revenue
1.40
Enterprise Value/EBITDA
11.74
Financial Highlights
Profitability and Income Statement
Profit Margin
6.91%
Return on Assets (ttm)
3.40%
Return on Equity (ttm)
7.07%
Revenue (ttm)
1.85B
Net Income Avi to Common (ttm)
128M
Diluted EPS (ttm)
1.27
Balance Sheet and Cash Flow
Total Cash (mrq)
598.78M
Total Debt/Equity (mrq)
6.74%
Levered Free Cash Flow (ttm)
254.23M